Results 31 to 40 of about 300,331 (272)

By protecting against cutaneous inflammation, epidermal pigmentation provided an additional advantage for ancestral humans. [PDF]

open access: yes, 2019
Pigmentation evolved in ancestral humans to protect against toxic, ultraviolet B irradiation, but the question remains: "what is being protected?" Because humans with dark pigmentation display a suite of superior epidermal functions in comparison with ...
Abuabara, Katrina   +7 more
core   +1 more source

Use of the complex of models of regression for analysis of the factors that determine the severity of bronchial asthma [PDF]

open access: yes, 2020
Background: According to an International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence of asthma in children of 6-7 years old has increased by 10%, and at the age of 13-14 years by 16% over the last decade.
Kozhyna, Olga S., Pihnastyi, O. M.
core   +1 more source

Emerging Methods to Objectively Assess Pruritus in Atopic Dermatitis. [PDF]

open access: yes, 2019
INTRODUCTION:Atopic dermatitis (AD) is an inflammatory skin disease with a chronic, relapsing course. Clinical features of AD vary by age, duration, and severity but can include papules, vesicles, erythema, exudate, xerosis, scaling, and lichenification.
Bhutani, Tina   +7 more
core   +1 more source

Atopic Dermatitis and Comorbidity [PDF]

open access: yesHealthcare, 2020
Atopic dermatitis is the most common chronic inflammatory skin disease. It is often the first indicator of allergic diseases, and a certain percentage of patients are affected by allergic rhinitis and/or asthma as a consequence. The study aimed to investigate the link between atopic dermatitis and comorbidity in family medicine.
Sanja Bekić   +5 more
openaire   +3 more sources

Update “Systemic treatment of atopic dermatitis” of the S2k‐guideline on atopic dermatitis

open access: yesJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021
This guideline is an update from August 2020 the S2k‐guideline “Atopic dermatitis” published in 2015. The reason for updating this chapter of the guideline were the current developments in the field of systemic therapy of atopic dermatitis.
T. Werfel   +21 more
semanticscholar   +1 more source

Systemic Immunomodulatory Treatments for Atopic Dermatitis

open access: yesJAMA dermatology
Key Points Question What is the relative efficacy and harm of lebrikizumab, the most recently approved biologic medication for atopic dermatitis compared with other systemic treatments?
Aaron M Drucker   +13 more
semanticscholar   +1 more source

Development and preliminary validation of a new screening questionnaire for identifying atopic children [PDF]

open access: yes, 2017
Background: Allergic diseases represent a frequent and increasing condition affecting children. A screening questionnaire allowing an easy identification of children with symptoms of allergic diseases may improve management and clinical outcome.
BRUSCOLINI, ALICE   +5 more
core   +1 more source

Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches

open access: yesFrontiers in Immunology
Atopic dermatitis, also known as atopic eczema, is a chronic inflammatory skin disease characterized by red pruritic skin lesions, xerosis, ichthyosis, and skin pain.
Moeina Afshari   +4 more
semanticscholar   +1 more source

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

open access: yesJAMA dermatology, 2020
This randomized clinical trial investigates the efficacy and safety of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis.
J. Silverberg   +10 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy